Mycobacterium tuberculosis

Associated infections

• Pulmonary tuberculosis
• Pleural, lymph node and miliary tuberculosis
• Skeletal tuberculosis including spinal disease
• Central nervous system tuberculosis and tuberculous meningitis
• Genitourinary and gastrointestinal tuberculosis
• Pericardial tuberculosis
• Latent tuberculosis infection

Transmission route

M. tuberculosis is transmitted person to person by inhalation of infectious droplet nuclei generated when a person with pulmonary or laryngeal tuberculosis coughs, sneezes, sings or speaks. Droplet nuclei are small enough to remain suspended in room air for extended periods and to reach the alveoli on inhalation, which is why control depends on ventilation, airborne precautions and respiratory protection rather than on surface hygiene. There is no waterborne route, no vector, and no meaningful environmental reservoir outside the human host.

Bronchoscopy is relevant on two counts: it is an aerosol-generating procedure requiring airborne precautions, and the bronchoscope itself can act as a vehicle for direct patient-to-patient transfer if reprocessing fails. Documented transmission has occurred through inadequate cleaning, inadequate high-level disinfection, use of a reprocessor not validated for the instrument, and damage to the instrument. In a United States outbreak investigation, ten patients had M. tuberculosis-positive bronchial specimens after bronchoscopy with a single instrument that was found to have a hole in its sheath; leak testing was not routinely performed at that institution, and two patients developed active disease.

The practical implication for endoscopy services is that M. tuberculosis control depends on device integrity and reprocessing discipline rather than on water quality. Leak testing after every use, thorough manual cleaning before disinfection, use of validated reprocessing cycles, and prompt removal of damaged instruments are the controlling measures. Isolation of M. tuberculosis in an endoscopy setting, or clustering of positive bronchial specimens, is a major infection-control escalation requiring instrument quarantine, molecular typing of isolates, review of the reprocessing record, and patient look-back, and it should not be managed as a water-system finding.

The corollary is equally important: improving rinse water quality will not reduce M. tuberculosis risk, and a facility that responds to a tuberculosis transmission event by upgrading its water treatment has addressed the wrong system. Conversely, a facility with excellent water quality and no leak testing programme remains exposed.

Relevance in endoscopy and reprocessing

M. tuberculosis is the exception in this group, and the distinction should be made explicitly rather than left implied. It is not a water organism. It does not colonise plumbing, does not form biofilm in distribution systems, does not persist in a reprocessor tank or a rinse line, and is not the reason AS/NZS 5369 requires mycobacterial monitoring of rinse water — that requirement addresses the non-tuberculous species. A water sample is not a meaningful place to look for M. tuberculosis, and a satisfactory water monitoring programme provides no protection against it.

Where it does matter in endoscopy is bronchoscopy, and there the controlling variables are device integrity and reprocessing execution. The Wisconsin outbreak investigation is the defining example: ten patients had M. tuberculosis-positive bronchial specimens after undergoing bronchoscopy with one instrument, that instrument was found to have a hole in its sheath, leak testing was not being performed routinely, and two patients went on to develop active disease. A breach in the outer sheath or in a channel wall admits organic material into spaces that neither manual cleaning nor disinfectant circulation can reach, so a cycle that is valid on paper is invalid in fact. Leak testing after every use is the single control that detects this failure, and it is not substitutable by any other step. Borescope inspection provides complementary information about internal channel condition, and instruments found to be damaged should be removed from service rather than reprocessed again.

Given correct cleaning and an intact instrument, high-level disinfection is effective against M. tuberculosis. Mycobactericidal activity is the benchmark against which high-level disinfectants are qualified, and glutaraldehyde, ortho-phthalaldehyde and peracetic acid all meet it at validated concentration, temperature and contact time. Manual cleaning is what makes that possible: organic soil both consumes disinfectant and physically shields organisms, and no chemistry compensates for a channel that was not brushed and flushed. Drying and storage matter less for this organism than for the NTM, since M. tuberculosis will not multiply in a wet channel the way an environmental mycobacterium will, though it does tolerate desiccation and standard drying and storage practice remains appropriate. Reprocessing personnel handling bronchoscopes from patients with suspected tuberculosis should be protected by the aerosol controls applicable to the procedure area itself.

Interpreting a detection

A report of M. tuberculosis from a water or final-rinse sample should be treated first as a probable identification error. The organism has no environmental reservoir and no mechanism for persisting in a water system, and several identification methods — particularly those relying on acid-fast staining, growth characteristics or probes with limited discrimination — can misassign an environmental NTM to M. tuberculosis complex. The first action is therefore to have the isolate referred to a reference mycobacteriology laboratory for confirmation by molecular methods, and to ask specifically whether M. tuberculosis complex has been distinguished from environmental species. Nothing about the water system should be concluded, and no remediation programme launched, before that confirmation returns.

If the identification is confirmed, the investigation shifts entirely away from water. The realistic explanations are contamination of the sample by clinical material, contamination in the laboratory during processing — cross-contamination between specimens is a well-recognised source of false-positive tuberculosis cultures — or contamination of the sampling pathway by an infectious person. Each is investigated through the specimen chain rather than through the plumbing: who collected the sample, in what environment, alongside what other specimens, and how it was processed. Molecular typing comparing the water isolate with recent clinical isolates from the same laboratory is often decisive.

The genuinely serious scenario in an endoscopy service is not a water detection but a clinical pattern: two or more patients with M. tuberculosis-positive bronchial specimens who share a bronchoscope, or a positive specimen in a patient with no clinical or radiological features of tuberculosis. That combination should trigger immediate escalation — quarantine of the implicated instrument, leak testing and borescope inspection, review of the full reprocessing record including cleaning, cycle parameters and reprocessor validation for that model, molecular typing of patient isolates to establish whether they are related, and a structured patient look-back covering procedures performed with the instrument since its last verified integrity check. Infection prevention, the endoscopy service, the microbiology laboratory and the relevant public health authority should be involved together, and notification obligations for tuberculosis apply. Water sampling has no role in that investigation.

Antimicrobial resistance

Drug-resistant tuberculosis is a major global concern. Multidrug-resistant tuberculosis is defined by resistance to at least isoniazid and rifampicin, the two most effective first-line agents, and requires longer regimens with less effective and more toxic drugs. Further resistance to fluoroquinolones and other key second-line agents defines pre-extensively and extensively drug-resistant disease, with correspondingly poorer outcomes. Resistance arises through chromosomal mutation selected by inadequate, interrupted or monotherapeutic treatment, and is then transmitted person to person in the same way as susceptible strains — an important point, since drug-resistant tuberculosis is frequently acquired directly rather than generated during an individual's own treatment. Rapid molecular testing for rifampicin and isoniazid resistance is recommended at diagnosis so that an effective regimen can be started without waiting for phenotypic results.

Separately, M. tuberculosis shows the general mycobacterial tolerance to low-level disinfectants. The mycolic-acid cell wall is hydrophobic and poorly permeable to hydrophilic biocides, which is why the organism sits high on the classical hierarchy of disinfectant resistance — above vegetative bacteria and enveloped viruses, below bacterial spores. This is precisely why endoscope reprocessing requires validated high-level disinfection preceded by effective manual cleaning, and why tuberculocidal activity is used as the benchmark for qualifying high-level disinfectants. It also means that intermediate- and low-level disinfectants suitable for environmental surfaces are not adequate for semi-critical devices.

What this tolerance does not imply is environmental persistence of the kind seen with non-tuberculous mycobacteria. M. tuberculosis does not persist or multiply in water systems, does not form plumbing biofilm, and is not protected by amoebal internalisation in an engineered water context. Its disinfectant tolerance is a reprocessing consideration, not a water treatment one, and no water system control measure addresses it.